What are the treatment options for migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Migraine Treatment Options

NSAIDs are the first-line treatment for most migraine sufferers, followed by triptans for moderate to severe attacks or when NSAIDs fail. 1

Acute Treatment Algorithm

First-Line Treatment

  • For mild to moderate attacks:

    • NSAIDs with strongest evidence 1:
      • Aspirin (650-1000 mg every 4-6 hours, max 4g/day)
      • Ibuprofen (400-800 mg every 6 hours, max 2.4g/day)
      • Naproxen sodium (275-550 mg every 2-6 hours, max 1.5g/day)
      • Combination of acetaminophen + aspirin + caffeine

    Note: Acetaminophen alone is NOT recommended for migraine 1

Second-Line Treatment

  • For moderate to severe attacks OR when NSAIDs fail:

    • Triptans 1:
      • Sumatriptan (oral: 25-100 mg; subcutaneous: 6 mg)
      • Rizatriptan (oral)
      • Zolmitriptan (oral)
      • Naratriptan (oral)

    Clinical pearl: Triptans are most effective when taken early in an attack while pain is still mild 1

Third-Line Treatment

  • When triptans fail or are contraindicated:
    • Dihydroergotamine (DHE) nasal spray 1
    • Newer agents (limited availability):
      • Ditans (lasmiditan)
      • Gepants (ubrogepant, rimegepant) 1
    • Rescue medications:
      • Opioids (use cautiously due to risk of dependence) 1
      • Butorphanol nasal spray 1

Special Considerations

  • For attacks with significant nausea/vomiting:
    • Use non-oral routes of administration 1
    • Add antiemetics like metoclopramide (10 mg) or prochlorperazine 1
    • Consider subcutaneous sumatriptan (6 mg) for rapid relief 1, 2

Preventive Treatment

Consider preventive therapy when 1:

  1. Two or more attacks per month with disability lasting ≥3 days
  2. Acute treatments fail or are contraindicated
  3. Using acute medications more than twice weekly
  4. Presence of uncommon migraine conditions (hemiplegic, prolonged aura, migrainous infarction)

First-Line Preventive Medications 1

  • Propranolol (80-240 mg/day)
  • Timolol (20-30 mg/day)
  • Amitriptyline (30-150 mg/day)
  • Divalproex sodium (500-1500 mg/day)
  • Sodium valproate (800-1500 mg/day)

Important Clinical Considerations

Medication Overuse Risk

  • Limit acute treatments to no more than twice weekly to prevent medication-overuse headache 1
  • Medication overuse can lead to chronic daily headaches and reduced effectiveness of treatments 2

Triptan Contraindications

  • Uncontrolled hypertension
  • Coronary artery disease
  • Basilar or hemiplegic migraine
  • Recent use of MAO inhibitors 2

Treatment Efficacy

  • Sumatriptan 50 mg and 100 mg provide better pain relief than 25 mg, with NNTs of 3.2 and 3.4 respectively for headache relief at 2 hours 3, 4
  • Early treatment during mild pain phase significantly improves outcomes 4
  • Subcutaneous sumatriptan provides the fastest relief but with more adverse effects 5

Adverse Effects

  • Most common triptan side effects: nausea, dizziness, chest/throat tightness, fatigue 2, 4
  • NSAIDs: GI upset, dizziness, risk of GI bleeding with prolonged use 1

Patient Education

  • Track migraine attacks with a diary to identify triggers and evaluate treatment response 1
  • Take medications early in the attack for optimal effectiveness 1
  • Avoid overuse of acute medications to prevent rebound headaches 1
  • Consider lifestyle modifications to address potential triggers 1

By following this stepped care approach and individualizing treatment based on attack severity, associated symptoms, and patient response, most migraine sufferers can achieve significant relief and improved quality of life.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Oral sumatriptan for acute migraine.

The Cochrane database of systematic reviews, 2003

Research

Sumatriptan (oral route of administration) for acute migraine attacks in adults.

The Cochrane database of systematic reviews, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.